Skip to content
Book a Demo >

Bio-Tech: Workforce Productivity Optimization

5105028

Industry

Manufacturing

Challenge

Bio-Tech needed deeper insight into how its workforce investments were impacting business performance as it prepared for patent expirations and rising R&D costs. Despite strong financial results, leadership lacked visibility into workforce productivity, contingent labor spending, and emerging talent risks. Without a clear view of Total Cost of Workforce (TCOW) and productivity benchmarks against competitors, the company struggled to identify where workforce investments could be optimized to sustain profitability and future growth.

Results

Through advanced workforce analytics and productivity benchmarking, Bio-Tech identified opportunities to improve workforce ROI, control rising contingent labor costs, and address compensation risks within key job families. The analysis highlighted targeted workforce optimization strategies that could deliver $45–$90 million in additional productivity gains and cost savings, while strengthening talent management and supporting long-term business performance.

Key Product

HR Reporting and Analysis Tools, Consulting

$45M+
PRODUCTIVITY & COST SAVINGS OPPORTUNITY
32,500
TOTAL WORKFORCE ANALYZED
3 YRS
WORKFORCE DATA ANALYZED FOR PRODUCTIVITY INSIGHTS
Private Edge (13)

About Bio-Tech

Bio-Tech, a global human therapy manufacturer, had experienced steady growth through acquisitions, improving both revenue and profitability. However, the company faced significant upcoming challenges including patent expirations and rising R&D costs.

To prepare for these headwinds, Bio-Tech’s new leadership initiated a company-wide transformation aimed at improving operational efficiency, sustaining profitability, and strengthening shareholder value.

 Human Resources played a key role in this transformation. Leadership needed deeper insight into how the workforce was impacting business outcomes and where productivity improvements could be made. With a workforce of 16,500 employees and 16,000 contingent workers, understanding total workforce investment and productivity became critical. 

The Challenge

Bio-Tech’s leadership needed to answer several strategic workforce questions:

  • How productive is Bio-Tech’s workforce compared to industry competitors?
  • Are workforce investments optimized for long-term growth?
  • Are human capital costs being effectively managed?
  • Are there emerging talent risks that could impact future performance?

While the company appeared successful financially, leadership suspected that deeper workforce metrics might reveal hidden inefficiencies and risks.

The Solution

Bio-Tech partnered with LYTIQS to conduct a comprehensive workforce productivity and cost analysis using the Human Capital Financial Statements (HCFS) framework. The analysis integrated workforce, talent acquisition, and payroll data across multiple HR systems including SAP, Kenexa BrassRing, Fieldglass, and Kronos to create a holistic view of workforce investment.

The study examined workforce trends from 2011–2014 and benchmarked Bio-Tech’s productivity against key competitors using both traditional and advanced workforce metrics. This approach allowed leadership to evaluate not only revenue and profit per employee, but also deeper indicators such as Human Capital ROI and Return on Human Capital Investment.

By introducing a Total Cost of Workforce (TCOW) model, the analysis provided a more accurate understanding of all workforce-related spending, including contingent labor. The evaluation also identified productivity “hot spots,” cost trends across divisions, and emerging compensation risks within critical job families, enabling leadership to pinpoint where workforce investments could be optimized.

The Results

The analysis revealed that while Bio-Tech outperformed peers on traditional productivity metrics, deeper workforce analytics uncovered opportunities to improve returns on talent investments and strengthen cost controls.

Key insights included rising contingent workforce costs that were offsetting internal headcount reductions, uneven workforce spending across business divisions, and emerging pay inequities in a critical job family where new senior hires were earning more than long-tenured high performers.

By implementing targeted workforce optimization strategies including tighter contingent labor management, divisional workforce cost controls, and adjustments to hiring and compensation strategies Bio-Tech was able to strengthen its workforce investment strategy.

The initiative confirmed at least $45 million in savings already achieved through restructuring efforts and identified an additional $45–$90 million in potential productivity and cost savings through improved workforce planning and talent management. These changes positioned Bio-Tech to maintain strong financial performance while preparing for future industry challenges and growth opportunities.

Ready to get started?

Let's Talk!